1. XIAP Antagonist Embelin Inhibited Proliferation of Cholangiocarcinoma Cells
    Cody J. Wehrkamp et al, 2014, PLoS ONE CrossRef
  2. mRNA Expression of Bax, Bcl-2, p53, Cathepsin B, Caspase-3 and Caspase-9 in the HepG2 Cell Line Following Induction by a Novel Monoclonal Ab Hep88 mAb: Cross-Talk for Paraptosis and Apoptosis
    Thantip Mitupatum et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
  3. Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells
    Nupur Nigam et al, 2015, PLOS ONE CrossRef
  4. Embelin can protect mice from thioacetamide-induced acute liver injury
    Huafeng Wang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  5. Embelin – a drug of antiquity: shifting the paradigm towards modern medicine
    Radhika Poojari, 2014, Expert Opinion on Investigational Drugs CrossRef
  6. Design, synthesis, and SAR of embelin analogues as the inhibitors of PAI-1 (plasminogen activator inhibitor-1)
    Fanglei Chen et al, 2014, Bioorganic & Medicinal Chemistry Letters CrossRef
  7. Synthesis and characterization of zinc oxide nanoparticles from Morus nigra and its anticancer activity of AGS gastric cancer cells
    Qing Tang et al, 2020, Journal of Photochemistry and Photobiology B: Biology CrossRef
  8. Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases
    Uzini Daimary et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef
  9. Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells
    Kirti S. Prabhu et al, 2017, PLOS ONE CrossRef